Contribution: SIF Stream 1- R&D
Arch Biopartners Inc.
$5,407,235.00
513415
FY 2020-21 · 2020-09-01
Summary
This project is to advance a lead therapeutic drug candidate through Phase II clinical trials to treat severe cases of COVID-19, specifically in the lungs, kidney and liver.
Program
SIF Stream 1- R&D
Recipient
Location
Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
101328227
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-09-01 | 2020-21 | $6,175,000.00 |
| 1 | 2020-09-01 | 2020-21 | $5,937,000.00 |
| 2 | 2020-09-01 | 2020-21 | $5,407,235.00 |
| 3 | 2020-09-01 | 2020-21 | $5,407,235.00 |
As published
Agreement End Date
2022-03-31
Agreement Number
513415
Agreement Start Date
2020-09-01
Agreement Title
513415
Agreement Title (French)
513415
Agreement Type
Contribution
Agreement Value
$5,407,235.00
Amendment Date
2023-04-04
Amendment Number
3
Description
This project is to advance a lead therapeutic drug candidate through Phase II clinical trials to treat severe cases of COVID-19, specifically in the lungs, kidney and liver.
Description (French)
Ce projet vise à faire avancer un médicament candidat de pointe dans des essais cliniques de phase II pour traiter des cas graves de COVID-19, en particulier pour les poumons, les reins et le foie.
Federal Riding
Toronto--St. Paul's
Federal Riding (French)
Toronto--St. Paul's
Federal Riding Number
35090
NAICS Code
541710
Organization Code
ic
Organization
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Program Name
SIF Stream 1- R&D
Program Name (French)
FIS Volet 1- R&D
Program Purpose
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
Program Purpose (French)
-favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé.
Recipient Business Number
101328227
Recipient City
Toronto
Recipient Country
CA
Recipient Legal Name
Arch Biopartners Inc.
Recipient Operating Name
Arch Biopartners Inc.
Recipient Postal Code
M4T2M5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
033-2020-2021-Q3-513415
